Search

Purpose The sensitivity of pseudo-continuous arterial spin labeling (PCASL) to off-resonance effects (ΔB0 ) is a major limitation at ultra-high field (≥7T). The aim of this study was to assess the effectiveness of different PCASL ΔB0 compensation methods at 7T and measure the labeling efficiency with off-resonance correction. Theory and methods Phase offset errors induced by ΔB0 at the feeding arteries can be compensated by adding an extra radiofrequency (RF) phase increment and transverse gradient blips into the PCASL RF pulse train. The effectiveness of an average field correction (AVGcor), a vessel-specific field-map-based correction (FMcor) and a vessel-specific prescan-based correction (PScor) were compared at 7T. After correction, the PCASL labeling efficiency was directly measured in feeding arteries downstream from the labeling location. Results The perfusion signal was more uniform throughout the brain after off-resonance correction. Whole-brain average perfusion signal increased by a factor of 2.4, 2.5, and 2.1, respectively, with AVGcor, FMcor and PScor compared to acquisitions without correction. With off-resonance correction, the maximum labeling efficiency was ~0.68 at mean B1 (B1mean ) of 0.70 µT when using a mean gradient (Gmean ) of 0.25 mT/m. Conclusion Either a prescan or a field map can be used to correct for off-resonance effects and retrieve a good brain perfusion signal at 7T. Although the three methods performed well in this study, FMcor may be better suited for patient studies because it accounted for vessel-specific ΔB0 variations. Further improvements in image quality will be possible by optimizing the labeling efficiency with advanced hardware and software while satisfying specific absorption rate constraints.

Central nervous system (CNS) infections are a major cause of human morbidity and mortality worldwide. Even patients that survive, CNS infections can have lasting neurological dysfunction resulting from immune and pathogen induced pathology. Developing approaches to noninvasively track pathology and immunity in the infected CNS is crucial for patient management and development of new therapeutics. Here, we develop novel MRI-based approaches to monitor virus-specific CD8+ T cells and their relationship to cerebrovascular pathology in the living brain. We studied a relevant murine model in which a neurotropic virus (vesicular stomatitis virus) was introduced intranasally and then entered the brain via olfactory sensory neurons – a route exploited by many pathogens in humans. Using T2*-weighted high-resolution MRI, we identified small cerebral microbleeds as an early form of pathology associated with viral entry into the brain. Mechanistically, these microbleeds occurred in the absence of peripheral immune cells and were associated with infection of vascular endothelial cells. We monitored the adaptive response to this infection by developing methods to iron label and track individual virus specific CD8+ T cells by MRI. Transferred antiviral T cells were detected in the brain within a day of infection and were able to reduce cerebral microbleeds. These data demonstrate the utility of MRI in detecting the earliest pathological events in the virally infected CNS as well as the therapeutic potential of antiviral T cells in mitigating this pathology.

Background Commercial low-field-strength MRI systems are generally not equipped with state-of-the-art MRI hardware, and are not suitable for demanding imaging techniques. An MRI system was developed that combines low field strength (0.55 T) with high-performance imaging technology. Purpose To evaluate applications of a high-performance low-field-strength MRI system, specifically MRI-guided cardiovascular catheterizations with metallic devices, diagnostic imaging in high-susceptibility regions, and efficient image acquisition strategies. Materials and Methods A commercial 1.5-T MRI system was modified to operate at 0.55 T while maintaining high-performance hardware, shielded gradients (45 mT/m; 200 T/m/sec), and advanced imaging methods. MRI was performed between January 2018 and April 2019. T1, T2, and T2* were measured at 0.55 T; relaxivity of exogenous contrast agents was measured; and clinical applications advantageous at low field were evaluated. Results There were 83 0.55-T MRI examinations performed in study participants (45 women; mean age, 34 years ± 13). On average, T1 was 32% shorter, T2 was 26% longer, and T2* was 40% longer at 0.55 T compared with 1.5 T. Nine metallic interventional devices were found to be intrinsically safe at 0.55 T (

Outliers in neuroimaging represent spurious data or the data of unusual phenotypes that deserve special attention such as clinical follow-up. Outliers have usually been detected in a supervised or semi-supervised manner for labeled neuroimaging cohorts. There has been much less work using unsupervised outlier detection on large unlabeled cohorts like the UK Biobank brain imaging dataset. Given its large sample size, rare imaging phenotypes within this unique cohort are of interest, as they are often clinically relevant and could be informative for discovering new processes. Here, we developed a two-level outlier detection and screening methodology to characterize individual outliers from the multimodal MRI dataset of more than 15,000 UK Biobank subjects. In primary screening, using brain ventricles, white matter, cortical thickness, and functional connectivity-based imaging phenotypes, every subject was parameterized with an outlier score per imaging phenotype. Outlier scores of these imaging phenotypes had good-to-excellent test-retest reliability, with the exception of resting-state functional connectivity (RSFC). Due to the low reliability of RSFC outlier scores, RSFC outliers were excluded from further individual-level outlier screening. In secondary screening, the extreme outliers (1,026 subjects) were examined individually, and those arising from data collection/processing errors were eliminated. A representative subgroup of 120 subjects from the remaining non-artifactual outliers were radiologically reviewed, and radiological findings were identified in 97.5% of them. This study establishes an unsupervised framework for investigating rare individual imaging phenotypes within a large neuroimaging cohort.

Microvascular Changes in the Brain in Covid-19 High-resolution MRI and histopathological study of the brains of patients who had died from Covid-19 showed punctate hyperintensities and punctate or ...

Meander-line, or zig-zag, MRI surface coils theoretically promise spatially uniform fields with optimal field localization close to the coil. In reality, they suffer poorer than expected field localizations and acquired images are often highly inhomogeneous, plagued by repeating stripe-like signal-loss artifacts. We show that both these detrimental effects arise from coil design based on the same invalid approximation in the underlying theory. Here, the conventional approximation is corrected, yielding a modified coil design that validates the new theory by rectifying the above problems. Specifically, an easily implementable coil correction, which amounts to the addition of a single extra turn of wire, is introduced and shown to increase signal uniformity by an order of magnitude, eliminate image artifacts, and reduce unwanted signal interference from deeper within the sample by tightening the coil field localization to close to the coil, as intended for zig-zag designs. With independent optimization of coil size and imaging depth possible, such corrected meander-lines surface coils may be well suited for large area, near-surface imaging and spectroscopy applications.

Central nervous system (CNS) infections are a major cause of human morbidity and mortality worldwide. Even patients that survive CNS infections can have lasting neurological dysfunction resulting from immune and pathogen induced pathology. Developing approaches to noninvasively track pathology and immunity in the infected CNS is crucial for patient management and development of new therapeutics. Here, we develop novel MRI-based approaches to monitor virus-specific CD8+ T cells and their relationship to cerebrovascular pathology in the living brain. We studied a relevant murine model in which a neurotropic virus (vesicular stomatitis virus) was introduced intranasally and then entered the brain via olfactory sensory neurons – a route exploited by many pathogens in humans. Using T2*-weighted high-resolution MRI, we identified small cerebral microbleeds as the earliest form of pathology associated with viral entry into the brain. Mechanistically, these microbleeds occurred in the absence of peripheral immune cells and were associated with infection of vascular endothelial cells. We monitored the adaptive response to this infection by developing methods to iron label and track individual virus specific CD8+ T cells by MRI. Transferred antiviral T cells were detected in the brain within a day of infection and were able to reduce cerebral microbleeds. These data demonstrate the utility of MRI in detecting the earliest pathological events in the virally infected CNS as well as the therapeutic potential of antiviral T cells in mitigating this pathology.

The UK Biobank (UKB) is a large-scale epidemiological study and its imaging component focuses on the pre-symptomatic participants. Given its large sample size, rare imaging phenotypes within this unique cohort are of interest, as they are often clinically relevant and could be informative for discovering new processes and mechanisms. Identifying these rare phenotypes is often referred to as "anomaly detection", or "outlier detection". However, anomaly detection in neuroimaging has usually been applied in a supervised or semi-supervised manner for clinically defined cohorts of relatively small size. There has been much less work using anomaly detection on large unlabeled cohorts like the UKB. Here we developed a two-level anomaly screening methodology to systematically identify anomalies from ~19,000 UKB subjects. The same method was also applied to ~1,000 young healthy subjects from the Human Connectome Project (HCP). In primary screening, using ventricular, white matter, and gray matter-based imaging phenotypes derived from multimodal MRI, every subject was parameterized with an anomaly score per phenotype to quantitate the degree of abnormality. These anomaly scores were highly robust. Anomaly score distributions of the UKB cohort were all more outlier-prone than the HCP cohort of young adults. The approach enabled the assessments of test-retest reliability via the anomaly scores, which ranged from excellent reliability for ventricular volume, white matter lesion volume, and fractional anisotropy, to good reliability for mean diffusivity and cortical thickness. In secondary screening, the anomalies due to data collection/processing errors were eliminated. A subgroup of the remaining anomalies were radiologically reviewed, and a substantial percentage of them (UKB: 90.1%; HCP: 42.9%) had various brain pathologies such as masses, cysts, white matter lesions, infarcts, encephalomalacia, or prominent sulci. The remaining anomalies of the subgroup had unexplained causes and would be interesting for follow-up. Finally, we show that anomaly detection applied to resting-state functional connectivity did not identify any reliable anomalies, which was attributed to the confounding effects of brain-wide signal variation. Together, this study establishes an unsupervised framework for investigating rare individual imaging phenotypes within large heterogeneous cohorts.

BACKGROUND AND PURPOSE: The manganese ion is used as an intracellular MR imaging contrast agent to study neuronal function in animal models, but it remains unclear whether manganese-enhanced MR imaging can be similarly useful in humans. Using mangafodipir (Teslascan, a chelated manganese-based contrast agent that is FDA-approved), we evaluated the dynamics of manganese enhancement of the brain and glandular structures in the rostral head and neck in healthy volunteers. MATERIALS AND METHODS: We administered mangafodipir intravenously at a rate of 1 mL/minute for a total dose of 5 μmol/kg body weight. Nine healthy adult volunteers (6 men/3 women; median age, 43 years) completed baseline history and physical examination, 3T MR imaging, and blood work. MR imaging also followed mangafodipir administration at various time points from immediate to 7 days, with delayed scans at 1–3 months. RESULTS: The choroid plexus and anterior pituitary gland enhanced within 10 minutes of infusion, with enhancement persisting up to 7 and 30 days, respectively. Exocrine (parotid, submandibular, sublingual, and lacrimal) glands also enhanced avidly as early as 1 hour postadministration, generally resolving by 1 month; 3 volunteers had residual exocrine gland enhancement, which resolved by 2 months in 1 and by 3 months in the other 2. Mangafodipir did not affect clinical parameters, laboratory values, or T1-weighted signal in the basal ganglia. CONCLUSIONS: Manganese ions released from mangafodipir successfully enable noninvasive visualization of intra- and extracranial structures that lie outside the blood-brain barrier without adverse clinical effects, setting the stage for future neuroradiologic investigation in disease.

PURPOSE: To develop switchable and tunable labels with high contrast ratio for MRI using magneto-caloric materials that have sharp first order magnetic phase transitions at physiological temperatures and typical MRI magnetic field strengths. METHODS: A prototypical magneto-caloric material Iron-Rhodium (FeRh) was prepared by melt mixing, high-temperature annealing, and ice-water quenching. Temperature and magnetic field dependent magnetization measurements of wire-cut FeRh samples were performed on a vibrating sample magnetometer. Temperature-dependent MRI of FeRh samples was performed on a 4.7T MRI. RESULTS: Temperature-dependent MRI clearly demonstrated image contrast changes due to the sharp magnetic state transition of the FeRh samples in the MRI magnetic field (4.7T) and at a physiologically relevant temperature (~37°C). CONCLUSION: A magneto-caloric material, FeRh, was demonstrated to act as a high contrast ratio switchable MRI contrast agent due to its sharp first order magnetic phase transition in the DC magnetic field of MRI and at physiologically relevant temperatures. A wide range of magneto-caloric materials are available that can be tuned by materials science techniques to optimize their response under MRI-appropriate conditions and be controllably switched in-situ with temperature, magnetic field, or a combination of both.

BACKGROUND: Genetically encoded calcium indicators (GECIs), especially the GCaMP-based green fluorescence GECIs have been widely used for in vivo detection of neuronal activity in rodents by measuring intracellular neuronal Ca(2+) changes. More recently, jRGECO1a, a red shifted GECI, has been reported to detect neuronal Ca(2+) activation. This opens the possibility of using dual-color GECIs for simultaneous interrogation of different cell populations. However, there has been no report to compare the functional difference between these two GECIs for in vivo imaging. Here, a comparative study is reported on neuronal responses to sensory stimulation using GCaMP6f and jRGECO1a that were virally delivered into the neurons in the somatosensory cortex of two different groups of animals, respectively. METHODS: GCaMP6f and jRGECO1a GECI were virally delivered to sensory cortex. After 3–4 weeks, the animals were imaged to capture the spatiotemporal changes of neuronal Ca(2+) and the hemodynamic responses to forepaw electrical stimulation (0.3 mA, 0.3 ms/pulse, 0.03 Hz). The stimulation-evoked neuronal Ca(2+) transients expressed with GCaMP6f or jRGECO1a were recorded during the baseline period and after an acute cocaine administration (1 mg/kg, i.v.). RESULTS: Histology confirmed that the efficiency of jRGECO1a and GCaMP6f expression into the cortical neurons was similar, i.e., 34%±3% and 32.7%±1.6%, respectively. Our imaging in vivo showed that the hemodynamic responses to the stimulation were the same between jRGECO1a and GCaMP6f expressed groups. Although the stimulation-evoked fluorescence change (∆F/F) and the time-to-peak of the neuronal Ca(2+) transients were not significantly different between these two indicators, the full-width-half-maximum (FWHM) duration of the ∆F/F rise in the jRGECO1a-expressed group (0.16±0.02 s) was ~50 ms or 46% longer than that of the GCaMP6f group (0.11±0.003 s), indicating a longer recovery time in jRGECO1a than in GCaMP6f transients (P